Novel mechanism therapies to treat severely high cholesterol for orphan and large markets1-10 Employees
LipimetiX careers
Small peptide Apo E mimetics direct free LDL to receptors on the liver and then fecal elimination. Strong animal data, ready for clinic with FDA accepted markers for efficacy. Lead indications: severely high cholesterol (Type II and Type III dyslipidemias) and acute coronary syndrome
LipimetiX hasn't added any jobs yet
Get notified when LipimetiX posts new jobs.
Fred Meyer
Managing Director at Exponential Pharma Partners and
VP Corporate Development at @LipimetiX
Phil Friden
Vice President R&D and Co-Founder at @LipimetiX, LLC
Eric Morrel
VP Clinical Research and Co-Founder at @LipimetiX
Dennis Goldberg
at @LipimetiX, LLC.
Glaxosmithkline • Seattle • $158k – $264k • 3 days ago
Acquia • Boston • $145k – $158k • 2 weeks ago
RF Venue • Walpole • 4 weeks ago
Simon Kucher & Partners • Old Toronto • 1 month ago
Veeva Systems • Columbus • $50k – $100k • 1 month ago